LY294002 has demonstrated its efficacy in inhibiting cell proliferation, inducing apoptosis, and suppressing tumor growth, while also attenuating EMT by suppressing the Akt-mediated regulation of EMT-related transcription factors and signaling pathways [65]. This evidence concerns the gene AKT1 and neoplasm.